AU2002246317A1 - Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof - Google Patents

Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof

Info

Publication number
AU2002246317A1
AU2002246317A1 AU2002246317A AU2002246317A AU2002246317A1 AU 2002246317 A1 AU2002246317 A1 AU 2002246317A1 AU 2002246317 A AU2002246317 A AU 2002246317A AU 2002246317 A AU2002246317 A AU 2002246317A AU 2002246317 A1 AU2002246317 A1 AU 2002246317A1
Authority
AU
Australia
Prior art keywords
isolation
pharmaceutical composition
composition containing
glucopyranoside
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002246317A
Other languages
English (en)
Inventor
Asha Bhagat
Om Parkash Gupta
Sukhdev Swami Handa
Rakesh Maurya
Deepa Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research
Original Assignee
Council of Scientific and Industrial Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research filed Critical Council of Scientific and Industrial Research
Publication of AU2002246317A1 publication Critical patent/AU2002246317A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU2002246317A 2002-04-08 2002-04-08 Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof Abandoned AU2002246317A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000105 WO2003087093A1 (en) 2002-04-08 2002-04-08 Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof

Publications (1)

Publication Number Publication Date
AU2002246317A1 true AU2002246317A1 (en) 2003-10-27

Family

ID=29227416

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002246317A Abandoned AU2002246317A1 (en) 2002-04-08 2002-04-08 Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof

Country Status (7)

Country Link
EP (1) EP1495019B1 (enExample)
JP (1) JP4309769B2 (enExample)
CN (1) CN1280290C (enExample)
AT (1) ATE399778T1 (enExample)
AU (1) AU2002246317A1 (enExample)
DE (1) DE60227421D1 (enExample)
WO (1) WO2003087093A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE510834T1 (de) 2003-03-14 2011-06-15 Astellas Pharma Inc C-glykosid-derivate zur behandlung von diabetes
AU2004261663A1 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
EP1679965A4 (en) 2003-08-01 2009-05-27 Janssen Pharmaceutica Nv SUBSTITUTED ANELLIERED HETEROCYCLIC C-GLYCOSIDES
WO2005012243A2 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted indole-o-glucosides
CA2549017A1 (en) 2003-08-01 2005-02-10 Mona Patel Substituted indazole-o-glucosides
CA2557320C (en) * 2004-03-04 2013-02-05 Kissei Pharmaceutical Co., Ltd. Fused heterocyclic derivatives for prevention or treatment of hyperglycemia
AU2005219779B2 (en) * 2004-03-04 2011-04-14 Kissei Pharmaceutical Co., Ltd. Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
CA2673498C (en) 2006-12-21 2012-04-24 Astellas Pharma Inc. Method for producing c-glycoside derivative and intermediate for synthesis thereof
TW201623321A (zh) * 2014-05-13 2016-07-01 韓美藥品股份有限公司 雙環衍生物及包含其之藥學組成物
CN106674311B (zh) * 2016-12-27 2019-02-05 西安交通大学 一种苯并呋喃苷类化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627611B2 (en) * 2000-02-02 2003-09-30 Kotobuki Pharmaceutical Co Ltd C-glycosides and preparation of thereof as antidiabetic agents

Also Published As

Publication number Publication date
EP1495019A1 (en) 2005-01-12
DE60227421D1 (de) 2008-08-14
CN1633432A (zh) 2005-06-29
CN1280290C (zh) 2006-10-18
ATE399778T1 (de) 2008-07-15
JP4309769B2 (ja) 2009-08-05
JP2005528398A (ja) 2005-09-22
EP1495019B1 (en) 2008-07-02
WO2003087093A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
WO2004037181A3 (en) Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
AU2002350191A1 (en) Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
AU2055500A (en) Aromatic amides
DE69831868D1 (en) Antithrombosemittel
PT958296E (pt) Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
WO2004018478A3 (en) Synthesis of epothilones, intermediates thereto, analogues and uses thereof
PL326203A1 (en) (methylsulphonyl)phenyl-2-(5)-furanones as cox-2 inhibitors
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
CA2234642A1 (en) 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
AU1185801A (en) Novel compounds
JO2390B1 (en) Diphenylcarboxamides act as lipid-lowering agents
WO2003087062A3 (en) 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
DE60227421D1 (de) Rmazeutische zusammensetzung und verwendung davon
AU3222195A (en) Organic compounds
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
WO2003080631A8 (en) Plasma carboxypeptidase b inhibitors
IL160820A0 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
WO2002070507A3 (en) Glycorticoid receptor antagonists for treatment of diabetes
NO990914L (no) Amorfe benzotiofener, fremgangsmÕter for fremstilling og fremgangsmÕter for anvendelse
ATE267832T1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase